Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamchatskenergo reported for 3 months of 2025 by RAS

5/6/25 KCHE

Ingrad Group of Companies sold 2.5 thousand hectares in the Moscow region

5/6/25 INGR

Shareholders of T-Technologies approved dividends for 2024

5/6/25 T

Softline reported for 3 months of 2025 by RAS

5/6/25 SOFL

Etalon Group exited the JV with Strana Development

5/6/25 ETLN

VK shareholders approved the additional share issue

5/6/25 VKCO

Moscow Exchange summarized the results of trading in April

5/5/25 MOEX

Himprom reported for 3 months of 2025 by RAS

5/5/25 HIMCP

European Electrotechnics reported for 3 months of 2025 by RAS

5/5/25 EELT

Court overturned the seizure of SMZ securities from buyers of shares on Moscow Exchange

5/5/25 MGNZ